Quest Diagnostics (DGX) Net Cash Flow Growth (3y) (2012 - 2026)
Quest Diagnostics (DGX) Net Cash Flow Growth (3y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.96 Bn | 209.90 Bn | 8.34 Bn | 58.74% |
| 2 | Danaher | 140.29 Bn | 135.94 Bn | 3.61 Bn | -43.12% |
| 3 | Idexx Laboratories | 46.08 Bn | 45.88 Bn | 779.09 Mn | -29.30% |
| 4 | Agilent Technologies | 39.78 Bn | 37.97 Bn | 990.00 Mn | 41.14% |
| 5 | Iqvia Holdings | 39.43 Bn | 37.35 Bn | 1.44 Bn | 27.97% |
| 6 | Natera | 38.72 Bn | 37.62 Bn | 696.04 Mn | 29.81% |
| 7 | Illumina | 30.05 Bn | 28.88 Bn | 770.00 Mn | -40.43% |
| 8 | Mettler Toledo International | 28.63 Bn | 28.58 Bn | 650.22 Mn | -38.01% |
| 9 | Quest Diagnostics | 26.17 Bn | 25.54 Bn | 1.03 Bn | 89.23% |
| 10 | Labcorp Holdings | 25.89 Bn | 24.91 Bn | 1.01 Bn | 138.15% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 89.23% |
| Mar 31, 2026 | 42.95% |
| Dec 31, 2025 | 67.68% |
| Sep 30, 2025 | 48.55% |
| Jun 30, 2025 | 17.64% |
| Mar 31, 2025 | -31.28% |
| Dec 31, 2024 | -21.84% |
| Sep 30, 2024 | 4.91% |
| Jun 30, 2024 | 32.84% |
| Mar 31, 2024 | -70.36% |
| Dec 31, 2023 | 47.59% |
| Sep 30, 2023 | -69.80% |
| Jun 30, 2023 | -27.57% |
| Mar 31, 2023 | 45.18% |
| Dec 31, 2022 | -35.86% |
| Sep 30, 2022 | -36.78% |
| Jun 30, 2022 | 34.04% |
| Mar 31, 2022 | -35.47% |
| Dec 31, 2021 | 3.51% |
| Sep 30, 2021 | 48.27% |